Table 1 Summary of dropout reasons by treatment at the final follow-up
Status | Magnesium, n (%) | Placebo, n (%) | Total, n (%) |
|---|---|---|---|
Baseline ASS assessment completed | 248 (49.4) | 254 (50.6) | 502 |
Completed follow-up | 185 (74.6) | 217 (85.4) | 402 (80.1) |
Overall dropout | 63 (25.4) | 37 (14.6) | 100 (19.9) |
Case 1: Due to good prognosis | 10 (15.9) | 5 (13.5) | 15 (15.0) |
Case 2: Due to poor prognosis | 1 (1.6) | 3 (8.1) | 4 (4.0) |
Case 3: Due to unknown or unclear reasons | 11 (17.4) | 9 (24.3) | 20 (20.0) |
Case 4: Unlikely to be related to the patient’s concurrent health status | 41 (65.1) | 20 (54.1) | 61 (61.0) |